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Abstract In this study, we demonstrate that the phosphoryla-
tion activity of five tyrosine kinases of the src family from both
human erythrocytes (lyn, hck and c-fgr) and bovine synapto-
somes (lyn and fyn) was stimulated by treatment with 30^250
WM peroxynitrite. This effect was not observed with syk, a non-
src family tyrosine kinase. Treatment of kinase immunoprecipi-
tates with 0.01^10 WM peroxynitrite showed that the interaction
of these enzymes with the oxidant also activated the src kinases.
Higher concentrations of peroxynitrite inhibited the activity of
all kinases, indicating enzyme inactivation. The addition of
bicarbonate (1.3 mM CO2) did not modify the upregulation of
src kinases but significantly protected the kinases against
peroxynitrite-mediated inhibition. Upregulation of src kinase
activity by 1 WM peroxynitrite was 3.5^5-fold in erythrocytes
and 1.2^2-fold in synaptosomes, but this could be the result, at
least in part, of the higher basal level of src kinase activity in
synaptosomes. Our results indicate that peroxynitrite can
upregulate the tyrosine phosphorylation signal through the
activation of src kinases.
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1. Introduction
Peroxynitrite, formed by the near di¡usion-limited reaction
of nitric oxide1 (NO) with superoxide (Oÿ2 ) [1^3], is a potent
oxidant that is believed to contribute to tissue injury in a wide
range of human diseases [4]. This oxidant may be formed by
cells generating simultaneously O32 and
NO as well as in
tissues over-expressing the inducible form of nitric oxide syn-
thase, an enzyme producing both radicals during its catalytic
process [5]. In biological samples, peroxynitrite2 reacts prefer-
entially with carbon dioxide and metal-centres of proteins
causing anti-oxidant depletion and oxidation/nitration of lip-
ids, proteins and DNA [4,6,7]. In tissues, where CO2 is 1^2
mM, the formation of the reactive peroxynitrite/CO2 adduct
(ONOOCO32 ) would be expected to drastically reduce the life-
time of peroxynitrite [8] and to inhibit, at least in part, protein
oxidations mediated by ONOO3 and ONOOH [9,10]. How-
ever, CO2 modulates but does not abolish peroxynitrite-de-
pendent oxidations. The current proposal is that, in the pres-
ence of substrates, a fraction (about 35%) of the short-lived
ONOOCO32 adduct can engage one-electron oxidation [11]
and aromatic nitration [12,13] probably through homolysis
to NO2 and CO3 radicals [14^16].
One of the major protein modi¢cations induced by peroxy-
nitrite is the oxidation/nitration of cysteines, tyrosines and
tryptophan residues [12,13,17^19]. Although nitration of tyro-
sine residues at the ortho-position (3-nitrotyrosine) and the
formation of stable S-nitrosothiols has been demonstrated in
several pathological tissues [20^22], the possible role of these
protein modi¢cations has not been fully explored.
Phosphorylation of key tyrosine residues plays a crucial role
in signal transduction and it has been proposed that one of
the deleterious e¡ects of peroxynitrite-mediated nitration of
tyrosine residues may be the downregulation of phosphotyr-
osine-dependent signalling [23,24]. However, increasing evi-
dence suggests that reactive oxygen and nitrogen species
may interfere with intracellular signalling pathways also by
upregulating tyrosine phosphorylation [25^29]. We have pre-
viously shown that 10^100 WM peroxynitrite upregulated the
erythrocyte band 3 tyrosine phosphorylation, while at higher
concentrations, tyrosine phosphorylation was downregulated
and, simultaneously, substrate nitration and inhibition of
phosphotyrosine kinase (PTKase) activity were observed
[26]. Although inhibition by peroxynitrite of phosphotyrosine
phosphatases may explain the elevated tyrosine phosphoryla-
tion of band 3 [26], the hypothesis that peroxynitrite directly
increases PTKase activity cannot be ruled out [27].
In this study, we investigated whether peroxynitrite can in-
crease protein tyrosine phosphorylation by activating
PTKases. Our results clearly demonstrated a selective activa-
tion of src PTKases by WM concentrations of peroxynitrite
not observed with p72syk (syk)3, another tyrosine kinase of
red blood cells. This e¡ect of peroxynitrite may lead to the
upregulation of src-dependent tyrosine signalling.
2. Materials and methods
2.1. Materials
[Q-32P]ATP (s 3000 Ci/mmol) was obtained from DuPont NEN
(Boston, MA, USA). Antibodies were obtained from the following
sources: anti-syk, anti-lyn, anti-hck, anti-c-fgr and anti-fyn from Santa
Cruz Biotechnology (Santa Cruz, CA, USA), anti-c-src clone 327
from Calbiochem (Cambridge, MA, USA), peroxidase-conjugated
anti-mouse and anti-rabbit antibodies from Amersham (Arlington
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1 The IUPAC-recommended name is nitrogen monoxide.
2 This term refers to both the anion ONOO3 and the di¡erent forms
of its conjugate acid ONOOH, peroxynitrous acid. The IUPAC-rec-
ommended name for the anion is oxoperoxonitrate (1-) and for per-
oxynitrous acid, it is hydrogen oxoperoxonitrate.
3 Hereafter in the text, we indicate the kinases as follows: p72syk, syk ;
p60src, c-src ; p53/56lyn, lyn ; p56/59hck, hck ; p55cÿfgr, c-fgr ; p59fyn, fyn.
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Heights, IL, USA). Nitrocellulose was obtained from Shleicher and
Schuell (Germany), Chelex 100 from Bio-Rad (Richmond, CA, USA)
and Immunopure-protein G or Trysacryl-immobilised protein A from
Pierce (Rockford, IL, USA). All other reagents were purchased from
Sigma Chemical (St. Louis, MO, USA).
2.2. Peroxynitrite preparation
Peroxynitrite was synthesised from sodium nitrite and hydrogen
peroxide and was stabilised by alkali as described by Radi et al.
[17]. The peroxynitrite preparation was treated with manganese diox-
ide (1 mg/ml, 30 min, 4‡C) to eliminate excess hydrogen peroxide. The
mixture was ¢ltered three times to remove the manganese dioxide.
When freeze-fractionated (380‡C), peroxynitrite solution forms a yel-
low top layer, which was retained for further studies. The top layer
typically contained 250^500 mM peroxynitrite. The peroxynitrite con-
centration was determined spectrophotometrically at 302 nm in 1.5 M
NaOH (O302 = 1670 M31 cm31). The contamination of nitrite of our
peroxynitrite preparation was 60^70% with respect to peroxynitrite.
2.3. Peroxynitrite treatment of erythrocytes and synaptosomes
Heparinised fresh human blood was obtained from healthy donors
following informed consent. After centrifugation for 10 min at
1000Ug, plasma and bu¡y coat were removed and red blood cells
were washed three times with isotonic phosphate-bu¡ered saline
(PBS), pH 7.4. Peroxynitrite anion is a relatively stable species, but
its protonated form is unstable and rapidly decomposes at a neutral to
acidic pH (t1=291 s). For this reason, peroxynitrite was added last and
as a bolus to erythrocytes suspended (2% hematocrit) in 30 mM NaCl,
80 mM phosphate bu¡er, 0.1 mM diethylenetriaminepenta-acetic acid
(DTPA), pH 7.2, and immediately mixed. After peroxynitrite treat-
ment, the erythrocytes were washed once in PBS. Synaptosomes were
prepared from bovine brain as previously described [30]. To avoid
metal-catalysed nitration by peroxynitrite [31], the phosphate bu¡er
was treated extensively with Chelex 100 and all samples contained
0.1 mM DTPA. Peroxynitrite was added as a single bolus directly
to synaptosomes suspended 1:10 (¢nal concentration 1 mg/ml) in
150 mM phosphate bu¡er, 0.1 mM DTPA, pH 7.5, and immediately
mixed. After 10 min at room temperature, synaptosomes were washed
once with the same phosphate bu¡er. When indicated, sodium bicar-
bonate was added to the phosphate bu¡er before the addition of
peroxynitrite. The CO2 level in the erythrocytes and synaptosomes
suspension and in phosphate bu¡ers was measured immediately be-
fore peroxynitrite addition with an ABL 330 (Radiometer, Copenha-
gen, Denmark). Decomposed peroxynitrite was obtained by adding
peroxynitrite to the phosphate bu¡er for 5 min at room temperature
before the addition of erythrocytes or synaptosomes (reversed order
of addition).
2.4. Western blot immunoassays
For Western blot analysis, proteins separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were trans-
ferred to nitrocellulose paper at 35 V overnight. Blots were then
washed with 50 mM Tris, 150 mM NaCl, pH 7.5 (TBS) and incubated
overnight with 5% non-fat dry milk in TBS. Washed nitrocellulose
¢lters were incubated overnight at 4‡C with the appropriate antibody.
After extensive washes in TBS-0.05% Tween 20, the presence of pro-
tein on a blot was revealed by chemiluminescence (ECL kit, Amer-
sham) and exposure to X-ray ¢lm.
2.5. Immunoprecipitation and immunocomplex kinase assay
Washed and packed erythrocytes (150 Wl) were diluted with 300 Wl
PBS and then lysed by addition of 150 Wl of 4URIPA bu¡er (100 mM
Tris, pH 7.5, 0.6 M NaCl, 4% Triton X-100, 4% Na-deoxycholate,
0.4% SDS, 20 Wg/ml leupeptin, 20 Wg/ml aprotinin, 4 mM phenyl-
methanesulfonyl £uoride (PMSF), 400 WM sodium o-vanadate,
40 WM phenylarsine oxide). After 10 min of incubation on ice, the
lysate was centrifuged at 12 000Ug for 10 min at 4‡C. The super-
natant was incubated for 1 h at 4‡C in a rotating wheel with 30 Wl
of Trysacryl-immobilised protein A and clari¢ed by centrifugation.
The supernatants were incubated for 3 h at 4‡C in a rotating wheel
with 20 Wl protein A-Trysacryl pre-adsorbed with the appropriate
polyclonal antibodies. The immunoprecipitation of syk was performed
by adding a monoclonal anti-syk antibody (overnight at 4‡C) and
then incubating with the immobilised protein G for 2 h at room
temperature in a rotating wheel. Synaptosomes were solubilised by
treatment for 10 min at 0‡C with an equal volume of 4URIPA bu¡er,
then diluted three times with PBS and centrifuged at 12 000Ug for
10 min at 4‡C. After clearing, the supernatants were incubated over-
night at 4‡C in a rotating wheel with the di¡erent antibodies.
Immunocomplexes were precipitated by addition of 50 Wl protein
A-Trysacryl. The immunoprecipitate, obtained from erythrocytes or
synaptosomes, was collected by centrifugation in a microfuge, washed
twice with 1URIPA bu¡er, twice with TBS and once with the kinase
bu¡er (20 mM Tris-HCl, pH 7.4, 10 mM MnCl2, 0.1 mM sodium
o-vanadate). The immunocomplex kinase assay was performed as pre-
viously described [30]. When indicated, the kinase assay was per-
formed in the presence of 1 Wg myelin basic protein (MBP) and sam-
ples were submitted to 15% SDS-PAGE to obtain a better separation
between kinases and MBP. The 32P-labelled proteins were quanti¢ed
by exposure of dried gels to a Phosphorimager instrument (Packard,
Camberra, CO, USA).
3. Results
3.1. Peroxynitrite modulates PTKase activities in intact
erythrocytes and synaptosomes
The human erythrocyte contains several tyrosine kinases of
the syk/ZAP70 (syk) and src (lyn, hck and c-fgr) families
whose function is to phosphorylate tyrosine residues of
some cellular proteins including the band 3 cytoplasmic do-
main [32^34]. To test the e¡ects of peroxynitrite on these
kinases, intact erythrocytes were treated with 0^1000 WM per-
oxynitrite and kinases were immunoprecipitated using the ap-
propriate antibody. Kinase activities were evaluated by an
immunocomplex kinase assay performed in the presence of
sodium o-vanadate to avoid the contribution of phosphotyr-
osine phosphatases.
As shown in lane 1 of Fig. 1A, the syk kinase assay of
untreated erythrocytes revealed a phosphorylated band at
72 kDa attributed to syk autophosphorylation (top panel)
Fig. 1. Peroxynitrite-dependent inhibition of the activity of syk ki-
nase. A: Immunocomplex kinase assay of anti-syk immunoprecipi-
tates obtained from erythrocytes treated with 0, 30, 100, 500 and
1000 WM peroxynitrite (lanes 1^5, respectively). The catalytic activ-
ity of syk was measured as autophosphorylation (top panel) or as
MBP phosphorylation (bottom panel). Proteins were resolved on
10% (top panel) or 15% (bottom panel) SDS-PAGE. B: Anti-syk
immunoblot of parallel anti-syk immunoprecipitates. The molecular
mass markers in kDa are indicated on the right.
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and a phosphorylated band at 22 kDa in samples where the
exogenous substrate MBP was added (bottom panel). The
phosphorylation of syk and MBP was slightly decreased by
up to 100 WM peroxynitrite and almost completely abolished
by 1000 WM (Fig. 1A, lanes 2^5). The identity of the 72 kDa
band as syk was veri¢ed by immunoblotting with anti-syk
monoclonal antibodies, which also revealed comparable
amounts of immunoprecipitated protein in all samples (Fig.
1B). To verify that the inhibitory e¡ect of peroxynitrite was
not due to contamination products or due to stable end-prod-
ucts of peroxynitrite decay, peroxynitrite was added to phos-
phate bu¡er before the addition of red blood cells. In this
experiment, the syk autophosphorylation and MBP phospho-
rylation activity was comparable to that of the control (results
not shown).
We next examined whether the treatment of intact erythro-
cytes with peroxynitrite a¡ected the activity of kinases of the
src family. Interestingly, the behaviour of these kinases dif-
fered from that of syk. Both autophosphorylation of the char-
acteristic p53/56 kDa doublet of lyn and the phosphorylation
of the exogenous substrate MBP were stimulated dose-de-
pendently by treatment with 30^200 WM peroxynitrite (Fig.
2A, lanes 1^4). The maximum activation of lyn was achieved
at 200 WM peroxynitrite (Fig. 2A, lane 4), while 500 WM
peroxynitrite inhibited lyn phosphorylation activity (Fig. 2A,
lane 5). To detect the amount of lyn in the rabbit polyclonal
anti-lyn immunoprecipitate, we used monoclonal anti-lyn anti-
bodies in the immunoblotting because the p53/56 kDa doublet
of lyn migrated in the gel in the same region as the immuno-
globulin G heavy chain (IgGH) (55 kDa). This minimises
cross-reaction between antibodies. As shown in Fig. 2B, per-
oxynitrite treatment did not change the lyn doublet intensity.
The same modulation by peroxynitrite of PTKase activity
was also observed for the hck and c-fgr kinases of red blood
cells (Fig. 2C and D, respectively). It should be noted that
with this kinase assay, in addition to the autophosphorylation
band, a phosphorylated band corresponding to the IgGH was
frequently observed, a ¢nding also reported by others [32].
Thus, if phosphorylated by the kinase, the IgGH may be
seen as an exogenous substrate. Interestingly, phosphorylation
of IgGH by hck and c-fgr was increased when erythrocytes
were treated with peroxynitrite up to 200 WM and decreased
at higher concentrations (Fig. 2C and D, lanes 2^5). Immu-
noblotting analysis of hck and c-fgr immunoprecipitates re-
vealed that the amount of proteins was identical in all samples
(results not shown). Control experiments with peroxynitrite
(0.01^1.0 mM) decomposed in phosphate bu¡er before the
Fig. 2. Peroxynitrite-induced modulation of the activity of lyn, hck and c-fgr kinases. Immunocomplex kinase assay of (A) anti-lyn (C) anti-hck
and (D) anti-c-fgr immunoprecipitates obtained from erythrocytes treated with 0, 30, 100, 200 and 500 WM peroxynitrite (lanes 1^5, respec-
tively). The catalytic activity of lyn was measured as autophosphorylation (A, top panel) or as MBP phosphorylation (A, bottom panel). Anti-
lyn immunoblot of the parallel anti-lyn immunoprecipitates is shown in (B). The molecular mass markers in kDa are indicated on the right.
Fig. 3. Peroxynitrite-induced modulation of the activity of neuronal
lyn and fyn kinases. Immunocomplex kinase assay of (A) anti-lyn
and (B) anti-fyn immunoprecipitates obtained from synaptosomes
treated with 0, 50, 100, 250, 500 and 1000 WM peroxynitrite (lanes
1^6, respectively). Proteins were resolved on 10% SDS-PAGE. The
molecular mass markers in kDa are indicated on the right.
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addition of erythrocytes or treatment of cells with 1 mM
nitrite revealed that the modulation of kinases was not due
to peroxynitrite decomposition or contaminating products (re-
sults not shown).
In a recent study, we observed that the c-src kinases of
synaptosomes were upregulated by peroxynitrite [30]. This
prompted us to investigate whether other kinases of synapto-
somes, which contain several kinases of the src family, includ-
ing lyn and fyn, were upregulated by peroxynitrite. The kinase
assay of anti-lyn and anti-fyn immunoprecipitates obtained
from peroxynitrite-treated synaptosomes revealed that the au-
tophosphorylation activity of these kinases was increased by
50^250 WM peroxynitrite and inhibited at higher concentra-
tions (Fig. 3A and B). The extent of src kinases upregulation
by peroxynitrite in synaptosomes was, however, lower than in
erythrocytes (compare Figs. 2 and 3).
It should be noted that only one isoform of the lyn kinase
was phosphorylated (probably the p53 kDa band). This result
agrees with the data reported by Achen et al. [35], who
showed that no band corresponding to the phosphorylated
p56 lyn isoform was observed in several bovine tissues. The
absence of the p56 lyn band was con¢rmed by immunoblot-
ting, which did not reveal a lyn doublet (results not shown).
Moreover, the lyn kinase assay showed a peroxynitrite-modu-
lated high molecular weight phosphorylated band at the top
of the gel (arrow in Fig. 3A). This band probably was not a
lyn aggregate because it was not recognised by the anti-lyn
antibody and thus may be due to co-precipitated high molec-
ular weight protein(s). In contrast to lyn, the fyn kinase phos-
phorylated the IgGH and in addition to the p59 kDa auto-
phosphorylation band of fyn, a peroxynitrite-modulated 55
kDa phosphorylated band was found (Fig. 3B). The immuno-
blotting of anti-lyn and anti-fyn immunoprecipitates revealed
that the amount of both proteins was not changed during
peroxynitrite treatment and no e¡ects on tyrosine kinase ac-
tivities were observed in samples treated with 30^1000 WM
decomposed peroxynitrite (results not shown).
3.2. Peroxynitrite modulates immunoprecipitated PTKase
activity
The above results suggest that one e¡ect of peroxynitrite is
to increase the activity of src kinases, but they do not rule out
the possibility that peroxynitrite may perform this action
through reactions occurring during cell treatment and preced-
ing the kinase immunoprecipitation. To de¢ne this question
further, we decided to immunoprecipitate the kinases and then
treated the immunoprecipitates with 0^1000 WM peroxynitrite.
Fig. 4. E¡ects of peroxynitrite on kinase activity of immunoprecipi-
tates. The kinases from (A) erythrocytes and from (B) synaptosomes
were immunoprecipitated with the speci¢c antibody and then treated
with 0^1000 WM peroxynitrite in 150 mM phosphate bu¡er, 0.1 mM
DTPA, pH 7.4, at room temperature for 5 min. Proteins were re-
solved on 10% SDS-PAGE. The extent of 32P incorporation in the
kinases was quanti¢ed in dried gels using a Phosphorimager instru-
ment and expressed as a percentage of the value in the relative un-
treated control samples. cpm values of untreated kinases in erythro-
cytes were: lyn 180 þ 85, hck 95 þ 40, c-fgr 35 þ 22, syk 43 þ 20 and
in synaptosomes: lyn 1130 þ 250, c-src 4260 þ 480, fyn 4750 þ 360.
The data are the mean values þ S.D. from three or four separate ex-
periments.
Fig. 5. E¡ects of CO2 on peroxynitrite-mediated modulation of ki-
nase activity. (A) immunocomplex assay of kinases (lyn and syk)
precipitated from peroxynitrite-treated erythrocytes. (B) Immuno-
complex assay of kinases precipitated from erythrocytes (lyn) and
synaptosomes (c-src) and then treated with peroxynitrite at the con-
centrations indicated. The hatched and black columns represent the
experiments performed in the absence and in the presence of 25 mM
bicarbonate, respectively. Data are mean values þ S.D. from three
separate experiments. The experimental procedure and cpm values
of untreated kinases are as in the legend of Fig. 4.
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The immunoprecipitates were submitted to an immunocom-
plex kinase assay and the extent of 32P incorporation in each
kinase was measured after SDS-PAGE separation.
As shown in Fig. 4, peroxynitrite up to a concentration of
1 WM was able to stimulate the autophosphorylation of all src
kinases obtained either from erythrocytes (lyn, hck and c-fgr)
or from synaptosomes (lyn, c-src and fyn). At 10 WM, only the
kinase activity of c-fgr from erythrocytes and that of lyn from
synaptosomes was signi¢cantly increased. Higher peroxyni-
trite concentrations induced a dramatic loss of kinase activity.
Treatment of the syk immunoprecipitate with peroxynitrite
only induced a dose-dependent inhibition (Fig. 4A). The au-
tophosphorylation signal in samples treated with decomposed
1^1000 WM peroxynitrite did not di¡er from that of the con-
trol samples.
As observed also in peroxynitrite-treated erythrocytes and
synaptosomes, the extent of activation induced by peroxyni-
trite on the immunoprecipitates was higher in erythrocyte
than in neuronal src kinases. The di¡erence may be due, at
least in part, to a higher basal level of activation of src kinases
in synaptosomes. This hypothesis was supported by the ob-
servation that the basal autophosphorylation activity of src
kinases was on average 30 times higher (range 6^140) in neu-
ronal than in erythrocyte forms (values in cpm are reported in
the legend to Fig. 4). The di¡erence in the extent of lyn acti-
vation was not due to di¡erence in the amount of immuno-
precipitated protein, since densitometric analysis of anti-lyn
immunoblottings revealed comparable amounts of p53lyn
from synaptosomes and p53/56lyn from erythrocytes (5.0
and 4.8 arbitrary units, respectively).
3.3. E¡ects of CO2 on peroxynitrite-mediated modulation of
tyrosine kinases
The high concentration of CO2 in tissues is expected to
signi¢cantly modify the peroxynitrite reactivity. We have re-
cently reported that the addition of 25 mM bicarbonate to
synaptosomes did not inhibit the upregulation of neuronal
c-src by peroxynitrite, but signi¢cantly protected kinases and
phosphatases against peroxynitrite inhibition [30]. We inves-
tigated the e¡ect of CO2 in the kinase activity of peroxyni-
trite-treated erythrocytes and we observed that the addition of
25 mM bicarbonate (1.3 mM CO2) did not modify the upre-
gulation of lyn activity by 100 WM peroxynitrite, but the ma-
jor e¡ect was a protection against kinase downregulation at
higher concentrations (Fig. 5A). CO2 protected also the per-
oxynitrite-induced inactivation of syk (Fig. 5A).
We further investigated the e¡ect of 25 mM bicarbonate on
the modulation by peroxynitrite of the autophosphorylation
activity of immunoprecipitated lyn and c-src (from erythro-
cytes and synaptosomes, respectively). As shown in Fig. 5B, in
the presence of 25 mM bicarbonate, the upregulation of lyn
and c-src induced by 1 WM peroxynitrite was maintained,
while the inhibitory e¡ect at 100 and 500 WM peroxynitrite
was reduced. The lower protection a¡orded by CO2 in these
experiments was probably due to the absence of the mem-
brane barrier (see Section 4). However, it should be stressed
that a signi¢cant concentration of CO2 was always present in
cells and in air-equilibrated bu¡ers even if bicarbonate was
not purposely added. The CO2 measured in red blood cells,
synaptosomes and phosphate bu¡ers without addition of bi-
carbonate was 0.13 þ 0.05, 0.24 þ 0.05 and 0.05 þ 0.02 mM
(n = 4), respectively. Thus, in experiments performed without
addition of bicarbonate, the formation of ONOOCO32 adduct
cannot be excluded.
4. Discussion
Treatment of cells with peroxynitrite has been reported to
induce several processes, including apoptotic cell death
[24,36]. However, the biochemical events involved in these
processes are still unclear and, since peroxynitrite is a physio-
logical oxidant, these may involve redox signalling pathways.
We and others [24^27,29] have shown that one of the e¡ects
of peroxynitrite is upregulation of the tyrosine phosphoryla-
tion signal. In this study, we have demonstrated that peroxy-
nitrite-induced tyrosine phosphorylation may occur through
the activation of some PTKases, in particular some of the
src family. The activity of src kinases was increased in asso-
ciation with tyrosine phosphorylation of exogenous sub-
strates. This e¡ect of peroxynitrite appears to be characteristic
of src, since the related but structurally di¡erent kinase syk
was not upregulated by peroxynitrite. The activation of src
kinases by peroxynitrite was not speci¢c to red blood cells but
was also observed in fyn, lyn and c-src kinases of synapto-
somes. We therefore deduced that the modulating e¡ect of
peroxynitrite is probably not tissue-speci¢c.
Results obtained by treatment of immunoprecipitates with
peroxynitrite support the hypothesis that this oxidant can ac-
tivate/inhibit PTKases. The inhibition of PTKases by peroxy-
nitrite may be due to oxidative modi¢cation(s) leading to loss
of catalytic activity, whereas enzyme activation may be linked
to the characteristic and multiple mechanisms of src kinase
activation. It has been shown, in fact, that both src autophos-
phorylation and the phosphorylation of substrates are in-
creased by a mechanism that probably involves enzyme struc-
tural modi¢cations induced by sulfhydryl oxidation [37].
Furthermore, the src-type kinases, in contrast to syk/ZAP,
possess a regulatory tyrosine residue (Tyr-527 for c-src) whose
phosphorylation/dephosphorylation modulates enzyme activ-
ity [38]. It is interesting to note that both cysteine and tyrosine
residues may be preferential targets of peroxynitrite and thus,
modi¢cation of one or more of these regulatory residues may
well explain the activation/inactivation of kinases. However, it
should be stressed that tyrosines, but particularly cysteines,
even if not modi¢ed directly by an oxidant molecule, may
act as a ‘sink’ for other more easily oxidisable residues [39].
Therefore, we do not rule out that modi¢cation of residues
critical for the enzymatic activity may be mediated by a ‘sink’
mechanism. The ¢nding that WM peroxynitrite can a¡ect cys-
teine- or tyrosine-regulated enzymatic activities is not unpre-
cedented [29,40^44], but whether these e¡ects are due to direct
oxidation of cysteine or tyrosine residues or are mediated
indirectly by ‘sink’ reactions requires further investigations.
Notwithstanding the multiple toxic processes attributed to
peroxynitrite [4,6,7], this oxidant in biological systems reacts
preferentially with a limited number of targets and one of this
is carbon dioxide. CO2 strongly modi¢es kinetic and toxic
properties of peroxynitrite [9,10]. However, the ONOOCO32
adduct probably does not ful¢l all peroxynitrite reactivity. For
example, the rate of peroxynitrite di¡usion inside the red
blood cell is so fast [45,46] that it travels up to 6 Wm and
reacts, at least in part, with hemoglobin before reacting ex-
tracellularly with CO2. The ONOOCO32 adduct formed ex-
tracellularly will decay before crossing the membrane (its
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life-time is too short to cross a membrane [8]) and, as a con-
sequence, only the ONOO3(H) escaped from the extracellular
capture or the ONOOCO32 formed intracellularly reacts with
biological targets. Obviously, peroxynitrite generated inside
the cell can react with intracellular targets more easily. How-
ever, it should be stressed that crossing of the plasmamem-
brane by the oxidant molecule is not obligatory for cell signal-
ling, since a stimulus at the membrane surface can induce
cytosolic enzyme processes such as thiol redox chemistry
[47]. In this work, we found that the upregulation of src ki-
nases by WM peroxynitrite was una¡ected by the increase of
CO2 from WM up to mM levels, while the inactivation of
kinases was protected by mM CO2. We speculate that the
activating e¡ect on src kinases may occur also with peroxyni-
trite generated extracellularly, whereas kinase inactivation
probably requires peroxynitrite-kinase closeness and trapping
of the oxidant by the enzyme before CO2. The occurrence of
kinase inhibition by peroxynitrite in a CO2-rich environment,
such as in vivo, is a matter of discussion but the resultant
inhibition of tyrosine signalling is expected to signi¢cantly
a¡ect cell functions [24].
Finally, in some cellular processes and in some cell types,
the activity of other tyrosine kinases, or even of src kinases,
may be di¡erently a¡ected by biological oxidants. For exam-
ple, the Janus kinase activity appears to be inhibited by NO-
donors [48] and peroxynitrite induced in epithelial cells the
activation of mitogen-activated protein kinases, another im-
portant class of tyrosine kinases involved in the cell response
to oxidative stress [29]. The e¡ects on src kinases described in
this study and the relatively low concentration needed for
upregulation (WM) suggest that peroxynitrite may regulate
src-dependent phosphotyrosine signalling, particularly in tis-
sues expressing high levels of the inducible nitric oxide syn-
thase.
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